Skip to content
Manuel Galvan

Manuel Galvan, PhD, is a complement biology expert at National Jewish Health. Dr. Galvan serves as the Director of the Complement Laboratory.

Special Interests




2003 - 2010
University of California Irvine, PhD in Anatomy and Neurobiology


Complement protein C1q and adiponectin stimulate Mer tyrosine kinase-dependent engulfment of apoptotic cells through a shared pathway. Galvan MD, Hulsebus H, Heitker T, Zeng E, Bohlson SS.
J Innate Immun. 2014;6(6):780-92

Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells. Galvan MD, Foreman DB, Zeng E, Tan JC, Bohlson SS. J Immunol. 2012  Apr 15;188(8):3716-23

Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Brain. 2010 Feb;133(Pt 2):433-47

Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. Galvan MD, Luchetti S, Burgos AM, Nguyen HX, Hooshmand MJ, Hamers FP, Anderson AJ. J Neurosci. 2008 Dec 17;28(51):

Human cord blood leukocyte innate immune responses to defense collagens. Maruyama H, Galvan M, Waffarn F, Tenner AJ. Pediatr Res. 2003 Nov;54(5):724-31